Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential
about
Pathogenesis of listeria-infected Drosophila wntD mutants is associated with elevated levels of the novel immunity gene edin.High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effectIncreased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.Increased circulating cytokines in patients with myocarditis and cardiomyopathy.The evolution of an inflammatory response.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase.The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.Enteric glial cells. An upstream target for induction of necrotizing enterocolitis and Crohn's disease?Secretory products of macrophages.Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6.The pathological evolution of multiple sclerosis.Possible roles of tumor necrosis factor in the pathology of malariaCachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.Cytokines in idiopathic inflammatory myopathies.Post-infectious disease syndrome.Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation.Anti-Inflammatory Effects of Ginsenoside Rg3 via NF-κB Pathway in A549 Cells and Human Asthmatic Lung Tissue.Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.Role of TLR2-dependent inflammation in metastatic progression.A proinflammatory mediator with potential relevance in aging.Targeted immunotherapy trials for idiopathic inflammatory myopathies.The role of NIGMS P50 sponsored team science in our understanding of multiple organ failure.Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.Cachetin/TNF: a macrophage protein that induces cachexia and shock.Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle. Implications for increased muscle lactate production in sepsis.Tumor necrosis factor inhibits human myogenesis in vitroParticipation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Tumor necrosis factor and endotoxin do not directly affect in vitro diaphragm function.Change of membrane potential is not required for the tumour necrosis factor-alpha mediated cytotoxicity.Gelam honey has a protective effect against lipopolysaccharide (LPS)-induced organ failure.The effects of recombinant tumour necrosis factor (cachectin) on metabolism in isolated rat adipocyte, hepatocyte and muscle preparations.Effect of inflammation on handgrip strength in the non-critically ill is independent from age, gender and body composition.Monocyte inflammatory mediators impair in vitro hamster diaphragm contractility.The role of channel formation in the mechanism of action of tumor necrosis factors.Impact of IL-10 on diaphragmatic cytokine expression and contractility during Pseudomonas Infection.
P2860
Q33354950-8FDBF12F-14F0-4654-99A8-9CDDB830333FQ33590797-20976CD5-B824-4ABC-B378-6B02F105282FQ33611681-09396CF5-B731-4B0C-B57A-657A5F461C51Q33614427-61407F3E-6C8B-4F02-9FAB-E0B4B2D64FC6Q33762821-7A29A577-A0C4-4A67-97AD-0EA75517E2E7Q33901722-C398C816-D664-4B7D-BEAF-839BB1BE0DD5Q34240870-6997B508-0D5A-4E0A-88C3-35AF0A973616Q34483183-EE49F3E3-F74E-4F73-8172-D280705F0240Q34522322-F306C23B-A654-4FB5-9056-BAE7CAC88BC5Q34557411-DA5776E3-1F19-49D0-BA8C-DBE893F362C4Q34616369-430EC82D-9225-46E9-82B3-C4A3908AD974Q35850662-187FA4D3-59F4-4B57-9042-C15B3A50344BQ35856237-E065082E-9564-4287-B7BE-410DF3275BBCQ36354640-EE7C157A-8AFA-4E17-8626-35CCD3F173B0Q36504371-7EE26C7B-A607-4D8A-B284-8B00BC5D0BB9Q36722447-58E29BEF-7BE6-437B-AFC1-94D0E381F802Q36923017-945F2CBD-B5E3-4D30-8C33-93D3C64B1004Q37575531-28D59F1C-4426-4F09-8A68-0D0164C923C3Q37831189-D27241AE-5236-4595-AB37-307FB72FB532Q37833132-48C642B2-00FC-481A-8E8E-5ED838F95AB9Q37962343-98B007B6-604C-45AC-9EB6-C76C8EBEC297Q38023207-16C0845A-5CE8-4339-AFE2-119EE080D71CQ38679752-FEEAA261-7E5C-448C-9BFD-40E68EDD12F3Q39527191-FBA6A1FB-3C40-4B5A-BBE2-2A36BBAD9A29Q39555654-6C94D279-71B3-4E51-B9D6-403538F94FF2Q39774053-BBBC25B7-A06B-43D5-B797-410E7C25FF60Q40649958-494D802F-4FCC-4E35-9E4E-603A1F9BFEA8Q41017625-1869FEAF-0BD3-4615-9FDC-9B53D49129A6Q41536829-3BE4A53A-5C7F-4A9F-BB85-916FD1100F37Q41588020-9D9BC5FE-BCCC-493C-B63E-8AE7DA6C2DCCQ41853495-EAF8DAA0-C87E-4265-81A1-6B2254108E3CQ42857133-C91AF5CD-64FF-47D9-A105-192007FCB503Q44673394-F57C9CDE-CD59-40FA-B3F5-8260E5725933Q45021306-B4A74D1D-4F08-427B-B0BD-85E8810982FFQ45942909-CEBAFB52-EB57-413E-9A18-F8DAF0067AD2Q53586855-5E548C39-8349-4A8F-8570-C1248C35F133
P2860
Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Cachectin/tumor necrosis facto ...... scle plasma membrane potential
@ast
Cachectin/tumor necrosis facto ...... scle plasma membrane potential
@en
type
label
Cachectin/tumor necrosis facto ...... scle plasma membrane potential
@ast
Cachectin/tumor necrosis facto ...... scle plasma membrane potential
@en
prefLabel
Cachectin/tumor necrosis facto ...... scle plasma membrane potential
@ast
Cachectin/tumor necrosis facto ...... scle plasma membrane potential
@en
P2093
P2860
P356
P1476
Cachectin/tumor necrosis facto ...... scle plasma membrane potential
@en
P2093
P2860
P304
P356
10.1084/JEM.164.4.1368
P407
P577
1986-10-01T00:00:00Z